Cancer Research UK partners with MedCity for 'Collaborate to Innovate London Diagnostics'
- Published date:
- June 2 2021
We’re partnering with MedCity on their new programme ‘Collaborate to Innovate London Diagnostics’ and offering £50,000 in funding to support the academic activities for one of the chosen projects.
MedCity's new programme ‘Collaborate to Innovate London Diagnostics’ is now open for applications. The year-long programme offers collaborative opportunities and grant-funded support for up to 10 London based SMEs with a valid diagnostic innovation. Each SME will be introduced to world-leading partners for matchmaking with academics, clinical researchers, major diagnostics companies, medical research charities, and evidence generation authorities.
We’re partnering with MedCity on this initiative and offering £50,000 in funding to support the academic activities for one of the chosen projects. In a recent interview, we explain why we’re excited to be involved in this unique programme and how it aligns to our Early Detection and Diagnosis of Cancer Roadmap.